Finch Trades: Relay Therapeutics (October 29, 2024)

Bottom-Up Insights
  • Trade: I purchased 172.56 shares of Relay Therapeutics at $5.795 per share on October 29, 2024.
  • Portfolio: Personal Brokerage
  • Rationale: My investment thesis for Relay Therapeutics is that motion-based drug design (MBDD) represents a rare step-change in the efficiency of drug development. By raising the probability of success (POS), investors can feel comfortable paying higher premiums for assets and the company as a whole.
  • Holding Period: As long as she'll have me

Want an email alert every time a Finch Trade goes live? Sign up in your profile.

This is simply a part of my ongoing, long-term position building for Relay Therapeutics. My long-term goal is to build a position of 10,000 shares or more before the business begins to ramp commercially.

If you aren't already on Discord, then join me and fellow members as we discuss biotech investing and this trade in a more timely manner.

The Trade

Relay Therapeutics is considered a Growth (Quality) position. I purchased 172.56 shares at $5.795 per share on October 29, 2024.